In patients with chronic epiphora due to partial, complete, or functional nasolacrimal duct obstruction, is lacrimal gland botulinum toxin injection more effective at reducing subjective symptoms as compared to placebo?
Latest Information Update: 01 Jul 2016
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Euphoria
- Focus Therapeutic Use
- 01 Jul 2016 New trial record